Rankings
▼
Calendar
LUNG Q2 2022 Earnings — Pulmonx Corporation Revenue & Financial Results | Market Cap Arena
LUNG
Pulmonx Corporation
$75M
Q2 2022 Earnings
Healthcare
Medical - Devices
Income Statement
Revenue
$14M
+14.3% YoY
Gross Profit
$10M
74.7% margin
Operating Income
-$14M
-103.3% margin
Net Income
-$15M
-104.9% margin
EPS (Diluted)
$-0.40
QoQ Revenue Growth
+29.3%
Cash Flow
Operating Cash Flow
-$10M
Free Cash Flow
-$10M
Stock-Based Comp.
$4M
Balance Sheet
Total Assets
$213M
Total Liabilities
$41M
Stockholders' Equity
$172M
Cash & Equivalents
$122M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$14M
$12M
+14.3%
Gross Profit
$10M
$9M
+15.4%
Operating Income
-$14M
-$13M
-13.6%
Net Income
-$15M
-$13M
-12.9%
Geographic Segments
UNITED STATES
$9M
62%
EMEA
$5M
33%
Asia Pacific
$724,000
5%
Other International Geographical Areas
$40,000
0%
← FY 2022
All Quarters
Q3 2022 →